E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/29/2005 in the Prospect News Biotech Daily.

SFBC priced target raised by Jefferies

SFBC International Inc. was reiterated by Jefferies & Co. analyst David Windley at a buy rating, and the price target on the stock was raised to $46 per share from $42 following second-quarter results. Dynavax shares Friday dropped $1.01, or 2.45%, to close at $40.24 on volume of 223,376 shares versus the three-month running average of 208,714 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.